PubMed · 15504349
Membrane-targeted peptides derived from Igalpha attenuate B-cell antigen receptor function.
Abstract
Within the B-cell antigen receptor (BCR), heterodimers of Igalpha/Igbeta couple the receptor to intracellular signaling pathways. In the resting state, Igalpha associates with Src-family tyrosine kinases (SFTKs) which contain some basal activity. Upon engagement of the receptor, the SFTKs phosphorylate tyrosine residues in the BCR that recruit and activate the tyrosine kinase Syk, initiating signaling pathways. To test the hypothesis that disrupting the association between the resting receptor and the SFTKs would attenuate both basal and induced receptor activities, we expressed non-phosphorylatable membrane-targeted analogs of Igalpha (Igalpha/M) or Igbeta (Igbeta/M) in B lymphocytes. Both Igalpha/M and Igbeta/M inhibited BCR-induced calcium mobilization, but only Igalpha/M was able to diminish tyrosine phosphorylation. In an immature B-cell line, Igalpha/M attenuated both receptor-induced and basal apoptosis. Taken together, these data demonstrate the importance of the resting receptor complex and suggest therapeutic strategies for regulating receptor-mediated functions.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Shara Kabak, Marcus R Clark. 2004-11-26. Membrane-targeted peptides derived from Igalpha attenuate B-cell antigen receptor function.. https://doi.org/10.1016/j.bbrc.2004.09.184
Cite the original work for its findings. Save a collection to share your selection of sources.